Search for: rheumatoid arthritis methotrexate autoimmune disease biomarker gene expression GWAS HLA genes non-HLA genes
| ID | PMID | Title | PublicationDate | abstract |
|---|---|---|---|---|
| 6751434 | [Antibodies to fibroblast antigens in the sera of rheumatism patients]. | 1982 Aug | The sera from patients with active rheumatic fever possess unmarked ability to react with antigens of human fibroblasts. More intense reactions were obtained with guinea-pig fibroblasts. In rheumatoid arthritis, positive reactions with human and guinea-pig fibroblasts were disclosed in half of the test sera. No complement-dependent cytotoxic antibodies were found in the patients' sera. | |
| 1138387 | The radiographic appearance of the rheumatoid hand. | 1975 Apr 26 | The early diagnosis of rheumatoid arthritis ensures a timeous prognosis and appropriate therapy for this chronic disease. The radiograph of the hand is a valuable aid in making this diagnosis, but accurate interpretation is difficult. An outline of the X-ray changes seen in the rheumatoid hand is presented, and the salient points in the differential diagnosis are outlined. | |
| 6752872 | [Pirprofen in the treatment of rheumatoid arthritis]. | 1982 Aug 28 | The efficacy and tolerance of pirprofen and ketoprofen in rheumatoid arthritis were compared in a cooperative, double-blind, cross-over trial involving 124 patients. Pirprofen 600 mg/day and ketoprofen 300 mg/day were given one after the other in a random order for two consecutive weeks. One hundred and ten patients were evaluated. Both drugs were comparable in efficacy, as evaluated on 12 different clinical and biological criteria with a tendency toward superiority for pirprofen. Pirprofen was very well tolerated by 79% and ketoprofen by 72% of the patients. Most of the side effects encountered were digestive disorders. In patients who received no other concomitant treatment, pirprofen was better tolerated than ketoprofen. Side effects were noted in only 9% of the patients under pirprofen, as against 25% under ketoprofen. | |
| 770080 | An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis. | 1976 | A trial to compare the therapeutic potential of 1200 mg. azapropazone daily with 3.9 g. aspirin daily was carried out in 108 out-patients with rheumatoid arthritis over a 14-day period. Analysis of results from the 85 patients with completed assessment data (49 on azapropazone; 36 on aspirin) showed that azapropazone was better than aspirin from the point of view of pain relief, number of days patients were withdrawn prematurely from the trial, and patient satisfaction with treatment. The differences, however, were not statistically significant. The authors compare the results obtained in this trial with those obtained previously from trials with 13 other antirheumatic drugs using the same method. | |
| 4731586 | Anserina bursitis. A treatable cause of knee pain in patients with degenerative arthritis. | 1973 Jul | The anserina bursa is located on the medial surface of the tibia deep to the tendons of the sartorius, gracilis, and semimembranosus muscles and superficial to the insertion of the tibial collateral ligament. Knee pain, a palpable swelling of the bursa, and tenderness over the medial anterior aspect of the tibia just below the knee are the hallmarks of anserina bursitis. In a three-year period, 24 patients with anserina bursitis were seen in a rheumatology clinic. All but one were women, 18 were obese, and only four were under 50 years old. Knee x-ray studies showed degenerative arthritis in 20 of the 24 patients. In ten, varus knee deformities were present, while three had valgus deformities. Ultrasound or local steroid injections gave dramatic relief in all but one patient. | |
| 845441 | Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble | 1977 | An assay system for the binding of Clq to insoluble IgG aggregates was found useful for the quantitation of immune complexes in biological fluids. The assay, both easily and rapidly performed, is based on the competition of Clq binding substances with IgG aggregates. Serum from rheumatoid arthritis patients showed an increase in Clq binding substances over normal serum and this increase could be abolished by pretreatment of the serum with D-penicillamine. | |
| 790545 | Ketoprofen in the treatment of rheumatoid arthritis. Double-blind, cross-over placebo comp | 1976 | In a two week double-blind cross-over trial of ketoprofen versus placebo in twelve patients, ketoprofen was shown to have substantial anti-inflammatory activity and to be more effective than placebo. Clinical and biological tolerance were excellent. | |
| 6391934 | Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis. | 1983 | This 10-week, double-blind, crossover study compared piroxicam (20 mg given once daily) and indomethacin (25 mg given three times daily) in patients with rheumatoid arthritis. In the 30 patients evaluated, both drugs produced statistically significant improvement after 4 weeks compared to placebo in all measured parameters with the exception of joint swelling and 10 m walking time. Piroxicam tended to provide greater improvement in the severity of pain and joint tenderness than indomethacin, while both drugs were equally effective in improving morning stiffness, grip strength, and range of joint motion, and in decreasing paracetamol consumption. Nevertheless, roughly two-thirds of the patients considered piroxicam to be the more effective agent. With both drugs side effects were mild and infrequent. | |
| 316461 | Patient compliance: a novel method of testing non-steroidal antiinflammatory analgesics in | 1979 Sep | Patient compliance has been used as a measure of efficacy of non-steroidal antiinflammatory drugs (NSAID) in the treatment of patients with rheumatoid arthritis. A series of studies on various cohorts of patients using different drugs and different prescribing methods has been conducted. The studies have confirmed the absence of long-term placebo response. Indomethacin emerges as the most effective drug regardless of the mode of prescription, but it is clear from the results that the level of compliance varies with the mode of prescription. | |
| 718273 | Lymphocyte studies in rheumatoid arthritis. II. Antibody-mediated and mitogen-induced lymp | 1978 Oct | A comparison was made of the activity of synovial fluid (SF) lymphocytes with peripheral blood lymphocytes in antibody-mediated and mitogen-induced lymphocyte cytotoxicity in patients with a variety of inflammatory joint diseases. SF lymphocytes consistently showed little or no antibody-mediated cytotoxicity (AMC) although mitogen-induced cytotoxic activity was comparable with that of the peripheral blood lymphocytes. Blocking substances on the cell surface were not responsible for the lack of AMC by SF lymphocytes as preincubation at 37 degrees C and enzyme treatment (trypsin, neuraminidase) of the cells did not restore activity. The lack of AMC by SF cells from a variety of inflammatory joint fluids demonstrates that this may be a consequence of inflammation in the joint and excludes the possibility that this is a specific property of fluids from certain conditions such as rheumatoid arthritis. Lymphocytes thought to be involved in AMC have a characteristic surface morphology (Fc receptor positive, E rosette negative, surface immunoglobulin negative). Such lymphocytes are present in synovial fluid in comparable proportions to those in blood. Hence the absence of AMC indicates that functional assays must be used in determining the presence or absence of cells with special functions. | |
| 4070984 | Irrigation treatment in split-thickness skin grafting of intractable leg ulcers. | 1985 | Continuous irrigation with saline through a felt dressing was used following mesh split-skin grafting of intractable leg ulcers. Antibiotics were added to the irrigation fluid in certain cases. Effective drainage of the grafted area was achieved and no signs of infection were seen. | |
| 399107 | [Intra-articular therapy with radionuclides]. | 1979 Nov 1 | The 12-year experiences of a working team with the intraarticular radiogold therapy in persisting synovialitides of chronic rheumatic diseases and resistant irritation phases of arthroses are supplementarily described and a critical valuation is performed. Finally practical conclusions for the local joint therapy are made, taking into consideration also the experiences of other investigators. | |
| 6971657 | Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring | 1981 Feb | The sera of 88 patient suffering from systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) containing antinuclear antibodies (ANA) were studied for: I) the complement fixing capacity of these ANAs: II) their immunoglobulin class. The results showed that: I) ANAs bind complement to a significant extent in 2 patients with SLE out of 3, but not in RA; II) the ANAs which bind complement belong partially or totally to the IgG class, while most of the ANAs from SLE not fixing complement belong to other classes; III) the ANAs from RA were most often from the IgM class and, surprisingly, they did not bind complement; IV) the occurrence of IgM ANA in SLE patients seems to be associated with clinical manifestations of arthritis. This double test (identification of ANA class and complement binding capacity), appears to be a valuable aid in the cases where diagnosis between RA and SLE is questionable. | |
| 75013 | Intratendon sheath corticosteroid treatment of rheumatoid arthritis-associated and idiopat | 1978 Jan | Flexor tenosynovitis (FT) is a common manifestation of rheumatoid arthritis (RA), contributing to hand deformity and manual dysfunction. The efficacy of intratendon sheath corticosteroids was assessed by reviewing the results of such treatment in 173 episodes of FT documented in 46 patients with definite or classic RA. Ninety-three percent of initial episodes resolved completely for 3 or more months (median: 25 months); tenosynovitis did not recur in 59%. The likelihood of a favorable response did not diminish with treatment of recurrent FT in a given digit. Comparable results were found in 52 FT episodes observed in 38 non-RA patients. No tendon sheath or soft tissue infection or tendon rupture ensued in either treatment group. The response was influenced by the specific corticosteroid preparation selected. Based on this experience, a trial of intratendon sheath corticosteroid injections prior to surgical intervention is recommended for RA patients with FT. | |
| 1156463 | [Critical considerations on the behavior of immunoglobulins in rheumatoid arthritis]. | 1975 May | Critical evaluation of immunoglobulins in Rheumatoid Arthritis. It has been studied the behavior of the serum and synovial immunoglobulins of 62 patients afftected arthritis reheumatoid in various clinic stages; the valued have been expressed in mg% and mg/g of proteins. The serum levels of the IgG and IgA are higher in the cases of R.A. than in normals. The synovial concentrations of the IgA and IgM are lower than the respective serum values, while the phenomenon is less evident for the IgG probably because the last are synthetised in the synovial means. It exists, however, a interdipendence between the concentration of the serum and synovial immunoglobulins. The concentrations of the immunoglobulines, both serum and synovial, are not in relation with the most usual humoral phlogosis-tests, as well as they are not correlable with the values of the naturals antiproteases and with some fractions of the complement (both of the classic and alternative pathway). The variations of the immunoglobulins are, in the R.A., aspecific and of different intensity therefore their determination is not proposable neither as test of measure of the phlogosis nor as index of disease. | |
| 3893441 | Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid | 1985 Jul | One hundred eighty-nine patients with rheumatoid arthritis were entered into a prospective, controlled, double-blind multicenter trial comparing placebo and methotrexate (MTX). One hundred ten patients completed 18 weeks of therapy. No remissions were seen, but patients able to tolerate low-dose pulse MTX therapy were significantly improved, compared with patients receiving placebo therapy, for all clinical variables measured, including joint pain/tenderness and swelling counts, rheumatoid nodules, and patient and physician assessment of disease activity. MTX treatment demonstrated statistically significant improvement over placebo in patients with anemia, elevated erythrocyte sedimentation rate, and rheumatoid factor. However, nearly one-third of the patients receiving MTX were withdrawn for adverse drug reactions, of which elevated levels of liver enzymes was the most common. Pancytopenia occurred in 2 patients taking MTX. All adverse drug effects resolved without sequelae. MTX appears to be effective in the treatment of active rheumatoid arthritis but requires close monitoring for toxicity. | |
| 303851 | Antigenic spectrum of soluble serum glycoproteins in rheumatoid arthritis. | 1977 Sep | Compared with healthy controls, rheumatoid arthritis patients were found to have higher serum (1 M) perchlorate filtrate (CHLF) levels of alpha-antitrypsin. In addition to orosomucoid, alpha2-HS-glycoprotein, haptoglobin, haemopexin and beta2-glycoprotein, the filtrate also contains detectable amounts of albumin, prealbumin and - in patients with high serum glycoprotein levels - also IgA. Serum sulphosalicylate filtrate (SF) contains chiefly orosomucoid, together with alpha1-antitrypsin, haptoglobin, haemopexin and beta2-glycoprotein. CHLF contains larger amounts of glycoprotein than SF. The glycoproteins of CHLF correlate with the patient's synovitis, while a high SF glycoprotein content, as estimated by the polarographic activity of the sulphydryl groups, tends to be indicative of visceral complications of RA. | |
| 7218258 | Levamisole as basic treatment of rheumatoid arthritis: longterm evaluation. | 1981 Jan | We evaluated longterm levamisole treatment of 201 rheumatoid patients. Fifty-nine patients in their 1st yr of treatment were not analyzed; of the remaining 142, 69 (49%) still took levamisole with benefit. Levamisole was stopped in 32 patients (22%) for inefficacy and for reversible adverse reactions in 37 (26%). Leukotoxic side-effects were the commonest cause of withdrawal (23 patients = 16%). Since June 1977, we administer levamisole on a 1 d/wk schedule (150 mg), with determination of white blood cells 10 h after intake to detect high-risk patients for agranulocytosis. With disease exacerbation during treatment or lack of response after 6 months, the drug is given on a 2nd non-consecutive day. Since June 1977, cases of agranulocytosis have not been observed. Allergic vasculitis did not occur with a 1 d/wk schedule. The absence of nephrotoxicity and hepatotoxicity is stressed. Only 4 patients (3%) were lost to follow-up. Comparison is made with longterm use of gold and D-penicillamine. We conclude that levamisole is a useful slow acting antirheumatic drug. | |
| 6776201 | The isolation of immune complexes containing IgM rheumatoid factor and recovery of IgG rhe | 1980 | IgG with rheumatoid factor activity has been recovered from immune complexes containing IgM rheumatoid factor. This was done by passing serum from patients with rheumatoid arthritis through an immunoadsorbent column of the F(ab')2 fragment of rabbit anti-human mu chain. The recovered IgM was analysed by radioimmunoassays for IgM and IgG rheumatoid factors before and after sucrose density gradient centrifugation at neutral and acid pH. It is considered that the method may be generally applicable for the isolation of immune complexes containing IgM antibodies. | |
| 1096285 | [Rheumatoid synovial fluid]. | 1975 Apr | In making a comparative study of different parameters in the examination of synovial fluid (rheumatoid factors, ragocytes, leucocytes, synovial complement, immunoglobulins) the authors show that rheumatoid fluid has characteristics that make differentiation from other inflammatory arthropathies possible on a statistical basis, thanks to the test for the homogeneity of the means. The presence of these characteristics seems to constitute a diagnostic argument which can be measured by mathematical methods. |